Implant's radiation source cleared by the FDA
This article was originally published in Clinica
Executive Summary
Implant Sciences has received US FDA 510(k) clearance for its radiation source, ytterbium-169, for treating cancers. The isotope could help replace current post-lumpectomy treatments for breast cancer, said the Wakefield, Massachusetts firm.